Pharmacological inhibition of c-Abl compromises genetic stability and DNA repair in Bcr-Abl-negative cells. (Q46685541)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362889 AND SRC:MED&resulttype=core&format=json

4 January 2020

title

Pharmacological inhibition of c-Abl compromises genetic stability and DNA repair in Bcr-Abl-negative cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362889 AND SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362889 AND SRC:MED&resulttype=core&format=json

4 January 2020

author name string

S Fanta

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362889 AND SRC:MED&resulttype=core&format=json

4 January 2020

M Sonnenberg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362889 AND SRC:MED&resulttype=core&format=json

4 January 2020

I Skorta

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362889 AND SRC:MED&resulttype=core&format=json

4 January 2020

J Duyster

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362889 AND SRC:MED&resulttype=core&format=json

4 January 2020

W E Aulitzky

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362889 AND SRC:MED&resulttype=core&format=json

4 January 2020

H van der Kuip

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362889 AND SRC:MED&resulttype=core&format=json

4 January 2020

language of work or name

English

0 references

publication date

24 March 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362889 AND SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362889 AND SRC:MED&resulttype=core&format=json

4 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362889 AND SRC:MED&resulttype=core&format=json

4 January 2020

issue

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362889 AND SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

4380-4384

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18362889 AND SRC:MED&resulttype=core&format=json

Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8.

4 January 2020

cites work

1 reference

Mutator phenotype of BCR--ABL transfected Ba/F3 cell lines and its association with enhanced expression of DNA polymerase beta

21 January 2018

1 reference

Werner syndrome protein phosphorylation by abl tyrosine kinase regulates its activity and distribution

21 January 2018

1 reference

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

21 January 2018

1 reference

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

21 January 2018

1 reference

Constitutive association of BRCA1 and c-Abl and its ATM-dependent disruption after irradiation

21 January 2018

1 reference

Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation

21 January 2018

1 reference

Cockayne syndrome protein B interacts with and is phosphorylated by c-Abl tyrosine kinase

21 January 2018

1 reference

Cardiotoxicity of the cancer therapeutic agent imatinib mesylate.

21 January 2018

1 reference

Functional interaction between DNA-PK and c-Abl in response to DNA damage

21 January 2018

1 reference

Dynamics of chronic myeloid leukaemia.

21 January 2018

1 reference

Role of poly(ADP-ribose) polymerase activity in imatinib mesylate-induced cell death

21 January 2018

1 reference

Increase in mutant frequencies in mice expressing the BCR-ABL activated tyrosine kinase

21 January 2018

1 reference

Role of c-Abl in the DNA damage stress response

21 January 2018

1 reference

A simple technique for quantitation of low levels of DNA damage in individual cells

21 January 2018

1 reference

Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia.

21 January 2018

1 reference

Imatinib mesylate (STI571) prevents the mutator phenotype of Bcr-Abl in hematopoietic cell lines

21 January 2018

1 reference

Regulation of cell death by the Abl tyrosine kinase

21 January 2018

1 reference

Insights into selective activation of p53 DNA binding by c-Abl.

21 January 2018

1 reference

Regulation of Rad51 Function by c-Abl in Response to DNA Damage

21 January 2018

1 reference

p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage

21 January 2018

1 reference

Determination of cell fate by c-Abl activation in the response to DNA damage

21 January 2018

1 reference